# Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients

> **NCT03258099** · — · UNKNOWN · sponsor: **Cui Yimin** · enrollment: 2200 (estimated)

## Conditions studied

- Solid Tumor
- Capecitabine
- Drug-Related Side Effects and Adverse Reactions
- Pharmacogenetics
- Pharmacokinetics

## Interventions

- **GENETIC:** detection of genotype

## Key facts

- **NCT ID:** NCT03258099
- **Lead sponsor:** Cui Yimin
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-28
- **Primary completion:** 2019-10
- **Final completion:** 2019-12
- **Target enrollment:** 2200 (ESTIMATED)
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03258099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03258099, "Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03258099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*